HCPLive Network

Gastroesophageal Reflux Disease (GERD)

Study results show that treatment with a proton pump inhibitor does not reduce the effectiveness of metformin treatment in patients with type 2 diabetes.
This 28-year-old woman presented with a large hyperpigmented patch on the right side of her upper back. Although the lesion developed over the past 2 years, it has been “sinking in” over the past 2 weeks. The patient denies any trauma, pain, discomfort, or pruritis, as well as any family history of cancers, lymphoma, or autoimmune disease. However, she has a history of gastroesophageal reflux disease and onychomycosis, and her grandfather has a similar lesion.
For patients with gastroesophageal reflux disease, those who receive a proton pump inhibitor prescription from gastroenterologists are more likely to be optimal users and have better symptom control, according to a study published in the June issue of the American Journal of Gastroenterology.
With no standards in place to guide referrals for children with gastroesophageal reflux disease, variation in procedural decision-making among pediatric subspecialists is expected.
A minimally-invasive, surgically-implanted esophagus band developed at Stony Brook University Hospital effectively reduces symptoms of gastroesophageal reflux disease (GERD).
Among patients with gastroesophageal reflux disease, laparoscopic sleeve gastrectomy does not resolve symptoms for most patients and can even induce symptoms, while gastric bypass is effective for many patients, according to a study published online Feb. 5 in JAMA Surgery.
GERD Upcoming Events
Boston, MA
June 9-12, 2014
Boston, MA
June 16-18, 2014
Fort Lauderdale, FL
July 30-31, 2014
Philadelphia, PA
October 17-22, 2014
Nashville, TN
April 15-18, 2015
Washington, DC
May 17-19, 2015
GERD Latest News
GERD Clinical Trials